Legal Representation
Attorney
Patricia I. Reding
USPTO Deadlines
Next Deadline
25 days remaining
NOA E-Mailed - SOU Required
Due Date
November 27, 2025
Extension Available
Until May 27, 2026
Application History
15 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Aug 28, 2025 | D1BR | I | TEAS DELETE 1(B) BASIS RECEIVED | Loading... |
| May 27, 2025 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Apr 1, 2025 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Apr 1, 2025 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Mar 26, 2025 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Mar 8, 2025 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Feb 4, 2025 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Feb 4, 2025 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Feb 4, 2025 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Nov 15, 2024 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Nov 15, 2024 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Nov 15, 2024 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Nov 15, 2024 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Oct 27, 2024 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| May 1, 2024 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 001
Chemical preparations being conjugating agents for use as pharmaceutical intermediates; chemical preparations for use in the manufacture of pharmaceuticals; diagnostic reagents for scientific use; reagents for scientific purposes
First Use Anywhere:
Jul 23, 2014
First Use in Commerce:
Jul 23, 2014
Class 005
Pharmaceutical preparations and substances for the treatment of viral diseases and disorders, neurological diseases and disorders, immune diseases and disorders, respiratory diseases and disorders, microbial infections and diseases, cancer, haematological diseases and disorders, gastro-intestinal diseases and disorders, inflammation, arthritis, hepatitis, anemia, coagulation diseases and disorders, pain, obesity, and diabetes; chemical preparations for medical use, namely, peptide and protein agents being pharmaceutical preparations for viral diseases and disorders, neurological diseases and disorders, immune diseases and disorders, respiratory diseases and disorders, microbial infections and diseases, cancer, haematological diseases and disorders, gastro-intestinal diseases and disorders, inflammation, arthritis, hepatitis, anemia, coagulation diseases and disorders, pain, obesity, and diabetes; diagnostic reagents for medical use
First Use Anywhere:
Jul 23, 2014
First Use in Commerce:
Jul 23, 2014
Class 042
Pharmaceutical research services; pharmaceutical product evaluation; inspection of pharmaceuticals; testing of pharmaceuticals; pharmaceutical drug development services; development of pharmaceutical preparations and medicines; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; providing scientific information in the field of pharmaceuticals; compilation and provision of scientific research information in the field of toxicology; toxicology research services in the nature of assessing toxicological information in relation to risks; chemical analysis services in the nature of assessing chemical information in relation to risks; provision of scientific information relating to the chemical industry
Classification
International Classes
001
005
042